Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hans-Georg Sahl

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Genes & Molecular Sequences

Concepts & Ideas

Living Beings

Procedures

Microbial Sensitivity Tests

Anatomy

Physiology

Post-Translational Protein Processing

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Henrichfreise Beate; Schiefer Andrea; Schneider Tanja; Nzukou Edith; Poellinger Christina; Hoffmann Theo-Julian; Johnston Kelly L; Moelleken Katja; Wiedemann Imke; Pfarr Kenneth; Hoerauf Achim; Sahl Hans Georg
Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed?
Marklein G; Josten M; Klanke U; Müller E; Horré R; Maier T; Wenzel T; Kostrzewa M; Bierbaum G; Hoerauf A; Sahl H-G
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates.
Antcheva Nikolinka; Morgera Francesca; Creatti Luisa; Vaccari Lisa; Pag Ulrike; Pacor Sabrina; Shai Yechiel; Sahl Hans-Georg; Tossi Alessandro
Artificial beta-defensin based on a minimal defensin template.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hans-Georg Sahl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Henrichfreise Beate; Schiefer Andrea; Schneider Tanja; Nzukou Edith; Poellinger Christina; Hoffmann Theo-Julian; Johnston Kelly L; Moelleken Katja; Wiedemann Imke; Pfarr Kenneth; Hoerauf Achim; Sahl Hans Georg
Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed?
Molecular microbiology 2009;73(5):913-23.
2009: Marklein G; Josten M; Klanke U; Müller E; Horré R; Maier T; Wenzel T; Kostrzewa M; Bierbaum G; Hoerauf A; Sahl H-G
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates.
Journal of clinical microbiology 2009;47(9):2912-7.
2009: Antcheva Nikolinka; Morgera Francesca; Creatti Luisa; Vaccari Lisa; Pag Ulrike; Pacor Sabrina; Shai Yechiel; Sahl Hans-Georg; Tossi Alessandro
Artificial beta-defensin based on a minimal defensin template.
The Biochemical journal 2009;421(3):435-47.
2009: Böttiger T; Schneider T; Martínez B; Sahl H-G; Wiedemann I
Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.
Applied and environmental microbiology 2009;75(13):4427-34.
2009: Schneider T; Gries K; Josten M; Wiedemann I; Pelzer S; Labischinski H; Sahl H-G
The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate.
Antimicrobial agents and chemotherapy 2009;53(4):1610-8.
2009: Bierbaum G; Sahl H-G
Lantibiotics: mode of action, biosynthesis and bioengineering.
Current pharmaceutical biotechnology 2009;10(1):2-18.
2009: Dischinger Jasmin; Josten Michaele; Szekat Christiane; Sahl Hans-Georg; Bierbaum Gabriele
Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.
PloS one 2009;4(8):e6788.
2008: Sass Vera; Pag Ulrike; Tossi Alessandro; Bierbaum Gabriele; Sahl Hans-Georg
Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge.
International journal of medical microbiology : IJMM 2008;298(7-8):619-33.
2008: Martínez Beatriz; Böttiger Tim; Schneider Tanja; Rodríguez Ana; Sahl Hans-Georg; Wiedemann Imke
Specific interaction of the unmodified bacteriocin Lactococcin 972 with the cell wall precursor lipid II.
Applied and environmental microbiology 2008;74(15):4666-70.
2008: Rosenfeld Yosef; Sahl Hans-Georg; Shai Yechiel
Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.
Biochemistry 2008;47(24):6468-78.
2008: Raafat Dina; von Bargen Kristine; Haas Albert; Sahl Hans-Georg
Insights into the mode of action of chitosan as an antibacterial compound.
Applied and environmental microbiology 2008;74(12):3764-73.
2008: Pag U; Oedenkoven M; Sass V; Shai Y; Shamova O; Antcheva N; Tossi A; Sahl H-G
Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'.
The Journal of antimicrobial chemotherapy 2008;61(2):341-52.
2008: Jones Tiffanny; Yeaman Michael R; Sakoulas George; Yang Soo-Jin; Proctor Richard A; Sahl Hans-Georg; Schrenzel Jacques; Xiong Yan Q; Bayer Arnold S
Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.
Antimicrobial agents and chemotherapy 2008;52(1):269-78.
2008: Sass Peter; Jansen Andrea; Szekat Christiane; Sass Vera; Sahl Hans-Georg; Bierbaum Gabriele
The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus.
BMC microbiology 2008;8():186.
2007: Christ Katrin; Wiedemann Imke; Bakowsky Udo; Sahl Hans-Georg; Bendas Gerd
The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques.
Biochimica et biophysica acta 2007;1768(3):694-704.
2006: Hancock Robert E W; Sahl Hans-Georg
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.
Nature biotechnology 2006;24(12):1551-7.
2006: Sahl Hans Georg
Optimizing antimicrobial host defense peptides.
Chemistry & biology 2006;13(10):1015-7.
2006: Steffen H; Rieg S; Wiedemann I; Kalbacher H; Deeg M; Sahl H-G; Peschel A; Götz F; Garbe C; Schittek B
Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge.
Antimicrobial agents and chemotherapy 2006;50(8):2608-20.
2006: Peschel Andreas; Sahl Hans-Georg
The co-evolution of host cationic antimicrobial peptides and microbial resistance.
Nature reviews. Microbiology 2006;4(7):529-36.
2006: Wiedemann Imke; Böttiger Tim; Bonelli Raquel R; Wiese Andre; Hagge Sven O; Gutsmann Thomas; Seydel Ulrich; Deegan Lucy; Hill Colin; Ross Paul; Sahl Hans-Georg
The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
Molecular microbiology 2006;61(2):285-96.
2006: Wiedemann Imke; Böttiger Tim; Bonelli Raquel Regina; Schneider Tanja; Sahl Hans-Georg; Martínez Beatriz
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
Applied and environmental microbiology 2006;72(4):2809-14.
2006: Chatterjee Indranil; Somerville Greg A; Heilmann Christine; Sahl Hans-Georg; Maurer Hans H; Herrmann Mathias
Very low ethanol concentrations affect the viability and growth recovery in post-stationary-phase Staphylococcus aureus populations.
Applied and environmental microbiology 2006;72(4):2627-36.
2006: Bonelli Raquel Regina; Schneider Tanja; Sahl Hans-Georg; Wiedemann Imke
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
Antimicrobial agents and chemotherapy 2006;50(4):1449-57.
2006: Bayer Arnold S; McNamara Peter; Yeaman Michael R; Lucindo Natalie; Jones Tiffanny; Cheung Ambrose L; Sahl Hans-Georg; Proctor Richard A
Transposon disruption of the complex I NADH oxidoreductase gene (snoD) in Staphylococcus aureus is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1.
Journal of bacteriology 2006;188(1):211-22.
2005: Zelezetsky Igor; Pag Ulrike; Sahl Hans-Georg; Tossi Alessandro
Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions.
Peptides 2005;26(12):2368-76.
2005: Brötz-Oesterhelt Heike; Beyer Dieter; Kroll Hein-Peter; Endermann Rainer; Ladel Christoph; Schroeder Werner; Hinzen Berthold; Raddatz Siegfried; Paulsen Holger; Henninger Kerstin; Bandow Julia E; Sahl Hans-Georg; Labischinski Harald
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.
Nature medicine 2005;11(10):1082-7.
2005: Zelezetsky Igor; Pacor Sabrina; Pag Ulrike; Papo Niv; Shai Yechiel; Sahl Hans-Georg; Tossi Alessandro
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity.
The Biochemical journal 2005;390(Pt 1):177-88.
2005: Sahl Hans-Georg; Pag Ulrike; Bonness Sonja; Wagner Sandra; Antcheva Nikolinka; Tossi Alessandro
Mammalian defensins: structures and mechanism of antibiotic activity.
Journal of leukocyte biology 2005;77(4):466-75.
2005: Zelezetsky Igor; Pag Ulrike; Antcheva Nikolinka; Sahl Hans-Georg; Tossi Alessandro
Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.
Archives of biochemistry and biophysics 2005;434(2):358-64.
2004: Kruszewska Danuta; Sahl Hans-Georg; Bierbaum Gabriele; Pag Ulrike; Hynes Sean O; Ljungh Asa
Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.
The Journal of antimicrobial chemotherapy 2004;54(3):648-53.
2004: Schneider Tanja; Senn Maria Magdalena; Berger-Bächi Brigitte; Tossi Alessandro; Sahl Hans-Georg; Wiedemann Imke
In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.
Molecular microbiology 2004;53(2):675-85.
2004: Hoffmann Anja; Schneider Tanja; Pag Ulrike; Sahl Hans-Georg
Localization and functional analysis of PepI, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5.
Applied and environmental microbiology 2004;70(6):3263-71.
2004: Wiedemann Imke; Benz Roland; Sahl Hans-Georg
Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study.
Journal of bacteriology 2004;186(10):3259-61.
2004: Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl H-G
In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
The Journal of antimicrobial chemotherapy 2004;53(2):230-9.
2003: Schaaff Franziska; Bierbaum Gabriele; Baumert Nicole; Bartmann Peter; Sahl Hans-Georg
Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus.
International journal of medical microbiology : IJMM 2003;293(6):427-35.
2003: Hsu Shang-Te D; Breukink Eefjan; Bierbaum Gabriele; Sahl Hans-Georg; de Kruijff Ben; Kaptein Rob; van Nuland Nico A J; Bonvin Alexandre M J J
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
The Journal of biological chemistry 2003;278(15):13110-7.
2002: Netz Daili Jacqueline Aguilar; Bastos Maria do Carmo de Freire; Sahl Hans-Georg
Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus.
Applied and environmental microbiology 2002;68(11):5274-80.
2002: Papo Niv; Oren Ziv; Pag Ulrike; Sahl Hans-Georg; Shai Yechiel
The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers.
The Journal of biological chemistry 2002;277(37):33913-21.
2002: Hoffmann Anja; Pag Ulrike; Wiedemann Imke; Sahl Hans-Georg
Combination of antibiotic mechanisms in lantibiotics.
Farmaco (Società chimica italiana : 1989) 2002;57(8):685-91.
2002: Netz Daili Jacqueline Aguilar; Pohl Regula; Beck-Sickinger Annette G; Selmer Thorsten; Pierik Antonio J; Bastos Maria do Carmo de Freire; Sahl Hans-Georg
Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus.
Journal of molecular biology 2002;319(3):745-56.
2002: Héchard Yann; Sahl Hans Georg
Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria.
Biochimie 2002;84(5-6):545-57.
2002: Guder André; Schmitter Tim; Wiedemann Imke; Sahl Hans-Georg; Bierbaum Gabriele
Role of the single regulator MrsR1 and the two-component system MrsR2/K2 in the regulation of mersacidin production and immunity.
Applied and environmental microbiology 2002;68(1):106-13.
2002: Baumert Nicole; von Eiff Christof; Schaaff Franziska; Peters Georg; Proctor Richard A; Sahl Hans-Georg
Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants.
Microbial drug resistance (Larchmont, N.Y.) 2002;8(4):253-60.
2002: Pag U; Sahl H-G
Multiple activities in lantibiotics--models for the design of novel antibiotics?
Current pharmaceutical design 2002;8(9):815-33.
2001: Netz D J; Sahl H G; Marcelino R; dos Santos Nascimento J; de Oliveira S S; Soares M B; do Carmo de Freire Bastos M;
Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus.
Journal of molecular biology 2001;311(5):939-49.
2001: Wiedemann I; Breukink E; van Kraaij C; Kuipers O P; Bierbaum G; de Kruijff B; Sahl H G
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
The Journal of biological chemistry 2001;276(3):1772-9.
2000: Brötz H; Sahl H G
New insights into the mechanism of action of lantibiotics--diverse biological effects by binding to the same molecular target.
The Journal of antimicrobial chemotherapy 2000;46(1):1-6.
2000: Beukes M; Bierbaum G; Sahl H G; Hastings J W
Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061.
Applied and environmental microbiology 2000;66(1):23-8.
2000: Guder A; Wiedemann I; Sahl H G
Posttranslationally modified bacteriocins--the lantibiotics.
Biopolymers 2000;55(1):62-73.
1999: Ryan M P; Jack R W; Josten M; Sahl H G; Jung G; Ross R P; Hill C
Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147.
The Journal of biological chemistry 1999;274(53):37544-50.
1999: Breukink E; Wiedemann I; van Kraaij C; Kuipers O P; Sahl H; de Kruijff B
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
Science (New York, N.Y.) 1999;286(5448):2361-4.
1999: Bierbaum G; Fuchs K; Lenz W; Szekat C; Sahl H G
Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(10):691-6.
1999: Pag U; Heidrich C; Bierbaum G; Sahl H G
Molecular analysis of expression of the lantibiotic pep5 immunity phenotype.
Applied and environmental microbiology 1999;65(2):591-8.
1998: Brötz H; Josten M; Wiedemann I; Schneider U; Götz F; Bierbaum G; Sahl H G
Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics.
Molecular microbiology 1998;30(2):317-27.
1998: Heidrich C; Pag U; Josten M; Metzger J; Jack R W; Bierbaum G; Jung G; Sahl H G
Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster.
Applied and environmental microbiology 1998;64(9):3140-6.
1998: Brötz H; Bierbaum G; Leopold K; Reynolds P E; Sahl H G
The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.
Antimicrobial agents and chemotherapy 1998;42(1):154-60.
1998: Sahl H G; Bierbaum G
Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria.
Annual review of microbiology 1998;52():41-79.
1997: Brötz H; Bierbaum G; Reynolds P E; Sahl H G
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
European journal of biochemistry / FEBS 1997;246(1):193-9.
1997: Neis S; Bierbaum G; Josten M; Pag U; Kempter C; Jung G; Sahl H G
Effect of leader peptide mutations on biosynthesis of the lantibiotic Pep5.
FEMS microbiology letters 1997;149(2):249-55.
1996: Molitor E; Kluczny C; Brötz H; Bierbaum G; Jack R; Sahl H G
Effects of the lantibiotic mersacidin on the morphology of staphylococci.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1996;284(2-3):318-28.
1996: Israil A M; Jack R W; Jung G; Sahl H G
Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis--frequency of lantibiotic production in coagulase-negative staphylococci.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1996;284(2-3):285-96.
1996: Heidrich C; Hantke K; Bierbaum G; Sahl H G
Identification and analysis of a gene encoding a Fur-like protein of Staphylococcus epidermidis.
FEMS microbiology letters 1996;140(2-3):253-9.
1996: Kuipers O P; Bierbaum G; Ottenwälder B; Dodd H M; Horn N; Metzger J; Kupke T; Gnau V; Bongers R; van den Bogaard P; Kosters H; Rollema H S; de Vos W M; Siezen R J; Jung G; Götz F; Sahl H G; Gasson M J
Protein engineering of lantibiotics.
Antonie van Leeuwenhoek 1996;69(2):161-69.
1996: Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl H G
The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
Antonie van Leeuwenhoek 1996;69(2):119-127.
1996: Bierbaum G; Szekat C; Josten M; Heidrich C; Kempter C; Jung G; Sahl H G
Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.
Applied and environmental microbiology 1996;62(2):385-92.
1995: Jack R; Bierbaum G; Heidrich C; Sahl H G
The genetics of lantibiotic biosynthesis.
BioEssays : news and reviews in molecular, cellular and developmental biology 1995;17(9):793-802.
1995: Meyer C; Bierbaum G; Heidrich C; Reis M; Süling J; Iglesias-Wind M I; Kempter C; Molitor E; Sahl H G
Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation.
European journal of biochemistry / FEBS 1995;232(2):478-89.
1995: Jack R W; Sahl H G
Unique peptide modifications involved in the biosynthesis of lantibiotics.
Trends in biotechnology 1995;13(7):269-78.
1995: van de Kamp M; van den Hooven H W; Konings R N; Bierbaum G; Sahl H G; Kuipers O P; Siezen R J; de Vos W M; Hilbers C W; van de Ven F J
Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7.
European journal of biochemistry / FEBS 1995;230(2):587-600.
1995: Sahl H G; Jack R W; Bierbaum G
Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
European journal of biochemistry / FEBS 1995;230(3):827-53.
1995: Brötz H; Bierbaum G; Markus A; Molitor E; Sahl H G
Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?
Antimicrobial agents and chemotherapy 1995;39(3):714-9.
1995: Bierbaum G; Brötz H; Koller K P; Sahl H G
Cloning, sequencing and production of the lantibiotic mersacidin.
FEMS microbiology letters 1995;127(1-2):121-6.
1995: van de Kamp M; Horstink L M; van den Hooven H W; Konings R N; Hilbers C W; Frey A; Sahl H G; Metzger J W; van de Ven F J
Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7.
European journal of biochemistry / FEBS 1995;227(3):757-71.
1995: Driessen A J; van den Hooven H W; Kuiper W; van de Kamp M; Sahl H G; Konings R N; Konings W N
Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles.
Biochemistry 1995;34(5):1606-14.
1994: Bierbaum G; Reis M; Szekat C; Sahl H G
Construction of an expression system for engineering of the lantibiotic Pep5.
Applied and environmental microbiology 1994;60(12):4332-8.
1994: Reis M; Eschbach-Bludau M; Iglesias-Wind M I; Kupke T; Sahl H G
Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product.
Applied and environmental microbiology 1994;60(8):2876-83.
1994: Jack R W; Carne A; Metzger J; Stefanovic S; Sahl H G; Jung G; Tagg J
Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22.
European journal of biochemistry / FEBS 1994;220(2):455-62.
1994: Sahl H G
Staphylococcin 1580 is identical to the lantibiotic epidermin: implications for the nature of bacteriocins from gram-positive bacteria.
Applied and environmental microbiology 1994;60(2):752-5.
1994: Jack R; Benz R; Tagg J; Sahl H G
The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22.
European journal of biochemistry / FEBS 1994;219(1-2):699-705.
1994: Sahl H G
Gene-encoded antibiotics made in bacteria.
Ciba Foundation symposium 1994;186():27-42; discussion 42-53.
1993: Bierbaum G; Sahl H G
Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1993;278(1):1-22.
1992: Kupke T; Stevanovic S; Sahl H G; Götz F
Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin.
Journal of bacteriology 1992;174(16):5354-61.
1992: Scott J C; Sahl H G; Carne A; Tagg J R
Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate.
FEMS microbiology letters 1992;72(1):97-102.
1990: Weil H P; Beck-Sickinger A G; Metzger J; Stevanovic S; Jung G; Josten M; Sahl H G
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids.
European journal of biochemistry / FEBS 1990;194(1):217-23.
1989: Schüller F; Benz R; Sahl H G
The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes.
European journal of biochemistry / FEBS 1989;182(1):181-6.
1989: Bierbaum G; Sahl H G
Influence of cationic peptides on the activity of the autolytic endo-beta-N-acetylglucosaminidase of Staphylococcus simulans 22.
FEMS microbiology letters 1989;49(2-3):223-7.
1989: Kordel M; Schüller F; Sahl H G
Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes.
FEBS letters 1989;244(1):99-102.
1988: Kordel M; Benz R; Sahl H G
Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes.
Journal of bacteriology 1988;170(1):84-8.
1987: Sahl H G; Ersfeld-Dressen H; Bierbaum G; Josten M; Kordel M; Reis M; Schüller F
Different mechanisms of insensitivity to the staphylococcin-like peptide Pep 5.
Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1987;267(2):173-85.
1987: Bierbaum G; Sahl H G
Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase.
Journal of bacteriology 1987;169(12):5452-8.
1987: Sahl H G; Kordel M; Benz R
Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin.
Archives of microbiology 1987;149(2):120-4.
1985: Sahl H G; Hahn C; Brandis H
Interaction of the staphylococcin-like peptide Pep 5 with cell walls and isolated cell wall components of Gram-positive bacteria.
Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1985;260(2):197-205.
1985: Kühnen E; Sahl H G; Brandis H
Purification and properties of LIQ 4, an antibacterial substance produced by Streptococcus faecalis var. liquefaciens K4.
Journal of general microbiology 1985;131(8):1925-32.
1985: Sahl H G
Bactericidal cationic peptides involved in bacterial antagonism and host defence.
Microbiological sciences 1985;2(7):212-7.
1985: Sahl H G; Grossgarten M; Widger W R; Cramer W A; Brandis H
Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin.
Antimicrobial agents and chemotherapy 1985;27(5):836-40.
1985: Bierbaum G; Sahl H G
Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes.
Archives of microbiology 1985;141(3):249-54.
1984: Ersfeld-Dressen H; Sahl H G; Brandis H
Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5.
Journal of general microbiology 1984;130(11):3029-35.
1984: Kader O A; Sahl H G; Brandis H
Isolation and mode of action of a staphylococcin-like substance active against gram-positive and gram-negative bacteria.
Journal of general microbiology 1984;130(9):2291-300.
1982: Budak A; Sahl H G; Brandis H
Antibacterial activities of Candida yeasts. Partial purification and characterization of the active substance of Candida guilliermondii.
Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectiousdiseases, parasitology 1982;253(3):390-6.
1982: Sahl H G; Brandis H
Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity.
Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectiousdiseases, parasitology 1982;252(2):166-75.
1981: Sahl H G; Brandis H
Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis.
Journal of general microbiology 1981;127(2):377-84.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hans-Georg Sahl

Research Profile (preview)

Chemicals & Drugs

Genes & Molecular Sequences

Concepts & Ideas

Living Beings

Procedures

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hans-Georg Sahl (preview)

All Publications